MedTrace Logo

A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines

NCT04545970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-09-16

No results posted yet for this study

Summary

This randomized, double-blind, placebo-controlled clinical trial was conducted to assess the efficacy and safety of an anti-aging serum to improve the appearance of expression lines as well as overall skin health of aging skin after 12 weeks of twice-daily use in female subjects, aged 35-60, compared to placebo. A total of 55 subjects completed study participation which included 33 subjects in the active group and 22 subjects in the placebo group.

Conditions

  • Fine Lines
  • Wrinkles
  • Photoaging

Interventions

COMBINATION_PRODUCT

Facial cleanser

Facial cleanser to be used by study participants

COMBINATION_PRODUCT

Facial moisturizer

Bland moisturizer to be used by study participants after serum in the evening.

COMBINATION_PRODUCT

Sunscreen

Sunscreen to be applied after application of serum in the morning.

Sponsors & Collaborators

  • Ablon Skin Institute Research Center

    collaborator OTHER

  • Revision Skincare

    lead INDUSTRY

Principal Investigators

  • Glynis Ablon, MD, FAAD · Ablon Skin Institute Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-23
Primary Completion
2020-03-11
Completion
2020-07-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04545970 on ClinicalTrials.gov